Hyponatremia Management
Management of hyponatremia is determined by three critical factors: symptom severity (mild vs. severe), chronicity (acute <48 hours vs. chronic >48 hours), and volume status (hypovolemic, euvolemic, or hypervolemic), with treatment intensity escalating from fluid restriction in asymptomatic cases to immediate hypertonic saline boluses for severe symptoms.
Initial Assessment Framework
Determine these three parameters immediately:
1. Symptom Severity:
- Severe symptoms: Seizures, coma, cardiorespiratory distress, obtundation, altered consciousness 1, 2, 3
- Mild symptoms: Nausea, vomiting, headache, weakness, confusion 4, 5
- Asymptomatic: Incidental finding
2. Chronicity:
3. Volume Status:
- Hypovolemic: No ascites/edema, signs of dehydration 3, 4
- Euvolemic: Normal volume status, consider SIADH 1, 8
- Hypervolemic: Ascites, edema, cirrhosis, heart failure 3, 9
Treatment Algorithm by Severity
Severe/Symptomatic Hyponatremia (Emergency)
Immediate action regardless of etiology:
- Administer 100-150 mL bolus of 3% hypertonic saline over 10-20 minutes 2, 7, 5
- Target: Increase sodium by 4-6 mEq/L within 1-2 hours to reverse cerebral edema 3, 5, 10
- Recheck sodium after bolus; repeat if severe symptoms persist
- Critical limit: Do NOT exceed 8-10 mEq/L increase in first 24 hours 2, 3, 7
- Monitor sodium every 2-4 hours initially 2
Rationale: Severe symptoms indicate cerebral edema requiring urgent reversal. The rapid bolus approach is preferred over continuous infusion for better control 7, 5.
Major pitfall: Overcorrection causes osmotic demyelination syndrome, especially in chronic hyponatremia, alcoholism, malnutrition, or cirrhosis 3, 5. Have desmopressin and hypotonic fluids ready to reverse overcorrection if needed 7.
Moderate Hyponatremia (Sodium 121-125 mEq/L)
With normal renal function:
- Cirrhosis patients: Stop diuretics, observe closely 11
- Non-cirrhosis: Treat based on volume status (see below)
With elevated creatinine (>150 μmol/L or rising):
- Stop all diuretics immediately 11
- Give volume expansion with colloid (albumin, gelofusine) or normal saline 11
- Rationale: Preventing irreversible renal failure takes priority over worsening ascites 11
Mild Hyponatremia (Sodium 126-135 mEq/L)
Cirrhosis with ascites:
Non-cirrhosis: Treat based on volume status
Severe Hyponatremia (Sodium <120 mEq/L)
All patients:
- Stop diuretics immediately 11
- If symptomatic: Hypertonic saline as above
- If asymptomatic: Volume expansion with colloid or saline 11
- Avoid increasing sodium >12 mEq/L per 24 hours 11
Treatment by Volume Status
Hypovolemic Hyponatremia
- Primary treatment: Normal saline infusion 3, 4
- Correct underlying cause (stop diuretics, address GI losses, adrenal insufficiency)
- Can use hypertonic saline if severely symptomatic 12
- Monitor closely: correction often occurs rapidly with volume repletion
Euvolemic Hyponatremia (SIADH)
First-line (asymptomatic):
- Fluid restriction 1-1.5 L/day 1, 9, 4
- Adequate solute intake (salt, protein) 7, 4
- Note: Nearly 50% fail fluid restriction alone 7
Second-line options:
- Oral urea (15-30 g/day): Very effective and safe 7, 5, 8
- Vaptans (tolvaptan): Effective but risk of overcorrection 3, 12, 5
- Salt tablets as adjunct 4
Hypervolemic Hyponatremia (Cirrhosis/Heart Failure)
Outpatient management (asymptomatic, sodium >125 mEq/L):
- Sodium restriction (90 mmol/day) 11
- Water restriction 1-1.5 L/day 12, 9
- Modify/reduce diuretics 9
- Increase laxatives (lactulose) 9
Inpatient management (symptomatic or sodium <125 mEq/L):
- Stop diuretics 9
- Water restriction 1-1.5 L/day 12, 9
- Consider intravenous albumin based on volume assessment 3, 9
- Oral vasoconstrictors (midodrine) may help 9
Refractory cases:
- Vaptans (tolvaptan, conivaptan): Effective short-term (1-4 weeks) but NOT for long-term use due to increased mortality in cirrhosis 3, 12
- Hypertonic saline ONLY if: severely symptomatic OR pre-liver transplant within days 3
- Warning: Hypertonic saline worsens ascites/edema 3, 12
- Consider TIPS for refractory cases 9
Critical Monitoring Parameters
- Sodium checks: Every 2 hours during acute treatment, then every 4-6 hours 2
- Daily weights and intake/output 2, 9
- Urine osmolality and sodium to guide therapy 1, 8
- Renal function (creatinine) especially in cirrhosis 11
Special Populations
Pre-liver transplant patients:
- Avoid severe hyponatremia (<125 mEq/L) to prevent osmotic demyelination during surgery 11
- Can use hypertonic saline cautiously if transplant imminent 3
- Correct slowly: 5 mEq/L in first hour, then <8 mEq/L per 24 hours 3
Neurosurgical patients:
- Distinguish cerebral salt wasting from SIADH 2
- Cerebral salt wasting: Treat with hypertonic saline + fludrocortisone 2
- SIADH: Fluid restriction unless severely symptomatic 2
Common Pitfalls to Avoid
Water restriction in cirrhosis with mild hyponatremia: Counterproductive, worsens effective hypovolemia and ADH secretion 11
Continuing diuretics when sodium <125 mEq/L: Risks irreversible renal failure 11
Overcorrection: Most dangerous complication. Use calculators, monitor frequently, have reversal agents ready 7, 5, 10
Long-term vaptan use in cirrhosis: Increases mortality; limit to 1-4 weeks maximum 3
Hypertonic saline in hypervolemic hyponatremia: Worsens volume overload; reserve for severe symptoms or pre-transplant only 3